<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03370497</url>
  </required_header>
  <id_info>
    <org_study_id>REACH EP 16/17_164B</org_study_id>
    <nct_id>NCT03370497</nct_id>
  </id_info>
  <brief_title>Calcium-protein Co-ingestion and Gut Hormones</brief_title>
  <official_title>The Acute Effects of Calcium-protein Co-ingestion on Gut Hormone Secretion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Bath</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Bath</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gut hormones have therapeutic potential in the prevention and treatment obesity and type 2
      diabetes (T2D). Rodent evidence suggests that calcium may potentiate the effects of protein
      ingestion on gut hormone secretion. Evidence in humans however, is lacking. This study aims
      to assess whether the addition of calcium to protein ingestion augments postprandial gut
      hormone availability in humans.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2017</start_date>
  <completion_date type="Actual">February 28, 2018</completion_date>
  <primary_completion_date type="Actual">January 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Randomised, double-blind crossover</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postprandial plasma GLP-1 area under the curve (mmol/L x 120 min).</measure>
    <time_frame>120 min</time_frame>
    <description>Postprandial plasma GLP-1 area under the curve (mmol/L x 120 min).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postprandial plasma GIP area under the curve (mmol/L x 120 min)</measure>
    <time_frame>120 min</time_frame>
    <description>Postprandial plasma GIP area under the curve (mmol/L x 120 min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postprandial plasma PYY area under the curve (mmol/L x 120 min)</measure>
    <time_frame>120 min</time_frame>
    <description>Postprandial plasma PYY area under the curve (mmol/L x 120 min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective ratings of appetite (au)</measure>
    <time_frame>120 min</time_frame>
    <description>Subjective ratings of appetite (au)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Obesity</condition>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Whey protein hydrolysate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Whey protein hydrolysate (50 g) will be consumed by participants in the morning between 8-10 am after 8-14 h fasting. Blood samples, appetite scales and expired breath samples will be taken in a regular intervals for 2 h after ingestion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Whey protein hydrolysate plus milk mineral supplement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Milk mineral supplement (equating to 1000 mg calcium) plus whey protein hydrolysate (50 g) will be consumed by participants in the morning between 8-10 am after 8-14 h fasting. Blood samples, appetite scales and expired breath samples will be taken in a regular intervals for 2 h after ingestion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Milk Mineral Supplement</intervention_name>
    <description>Milk Minerals containing 1000 mg calcium</description>
    <arm_group_label>Whey protein hydrolysate plus milk mineral supplement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Whey Protein Hydrolysate</intervention_name>
    <description>50 g whey protein hydrolysate</description>
    <arm_group_label>Whey protein hydrolysate</arm_group_label>
    <arm_group_label>Whey protein hydrolysate plus milk mineral supplement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy men and women age between 18-65 yrs.

          -  Able to consume provided supplement.

          -  Weight stable for the past 3 month (no change within 3%)

        Exclusion Criteria:

          -  Any previous or current metabolic, cardio-pulmonary or musculoskeletal disease

          -  Not between the ages of 18-65 years

          -  A body mass index below 18.9 kg/m2 or above 30 kg/m2 (body mass (kg) divided by your
             height (m) squared)

          -  Taking medications that may influence your metabolism

          -  Plans to change your lifestyle (diet and/or physical activity) during the study period

          -  Not willing to refrain from alcohol containing drinks or unaccustomed exercise one day
             before the laboratory sessions.

          -  Current smoker
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department for Health, University of Bath</name>
      <address>
        <city>Bath</city>
        <zip>BA2 7AY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 6, 2017</study_first_submitted>
  <study_first_submitted_qc>December 11, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 12, 2017</study_first_posted>
  <last_update_submitted>March 30, 2018</last_update_submitted>
  <last_update_submitted_qc>March 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Bath</investigator_affiliation>
    <investigator_full_name>Javier Gonzalez</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hormones</mesh_term>
    <mesh_term>Calcium, Dietary</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Anonymised data will be shared with publication</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

